Cargando…

Did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? The therapeutic effect compared by a Bayesian network meta-analysis.

BACKGROUND: Oral mucositis (OM) is one of the most common adverse effects of radiotherapy and chemotherapy. It greatly affects the patients' quality of life and hinders cancer treatment implementation. Treating OM with mouthwash is a widely used strategy that can effectively relieve symptoms an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xue, Zeng, Li, Feng, Xue, Zhao, Na, Feng, Na, Du, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926969/
https://www.ncbi.nlm.nih.gov/pubmed/36798750
http://dx.doi.org/10.3389/froh.2022.977830
_version_ 1784888384447053824
author Wang, Xue
Zeng, Li
Feng, Xue
Zhao, Na
Feng, Na
Du, Xin
author_facet Wang, Xue
Zeng, Li
Feng, Xue
Zhao, Na
Feng, Na
Du, Xin
author_sort Wang, Xue
collection PubMed
description BACKGROUND: Oral mucositis (OM) is one of the most common adverse effects of radiotherapy and chemotherapy. It greatly affects the patients' quality of life and hinders cancer treatment implementation. Treating OM with mouthwash is a widely used strategy that can effectively relieve symptoms and promote healing. However, the wide mouthwash selection confuses clinicians. This Bayesian network meta-analysis aimed to compare the effects of various mouthwash types used to treat OM and provide high-level evidence-based recommendations for OM treatment. METHODS: Database search included PubMed, Embase, Cochrane Library, and Web of Science from inception to April 21, 2022. The primary outcome was OM score improvement following the World Health Organization grades. The randomized controlled trial (RCT) bias risk assessment tool provided in the Cochrane Handbook assessed the studies' risk of bias. We performed pairwise and Bayesian network meta-analysis with random effects following the PRISMA guideline. RESULTS: The study included 13 RCTs with 570 patients. Pairwise comparisons showed that povidone-iodine was more effective than chlorhexidine (weighted mean difference [WMD], −2.64; 95% confidence interval [CI], −2.72 to −2.56) but inferior to granulocyte-macrophage colony-stimulating factor (GM-CSF; WMD, 0.20; 95% CI, 0.06–0.34) after one week of mouthwash treatment. Vitamin E (WMD, −0.94; 95% CI, −1.03 to −0.85), natural drugs (WMD, −0.93; 95% CI, −1.46 to −0.40), and phenytoin (WMD, −0.38; 95% CI, −0.59 to −0.17) exhibited better therapeutic effects than a placebo after three weeks of treatment. Bayesian network meta-analysis showed that povidone-iodine was superior to chlorhexidine in treating OM (WMD, 2.63; 95% CI, 0.20–5.01). Other mouthwashes showed no significant differences. Rank probability indicated that the best OM therapeutic mouthwashes were GM-CSF (54%), vitamin E (24%), and natural drugs (43%) after one, two, and three weeks of treatment, respectively. CONCLUSION: GM-CSF was the most effective mouthwash type for OM treatment. When considering the cost and effectiveness, povidone-iodine and sodium bicarbonate might be the most advantageous. Furthermore, natural drugs have the same potential in treating OM. Safety and acceptability are their most outstanding characteristic.
format Online
Article
Text
id pubmed-9926969
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99269692023-02-15 Did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? The therapeutic effect compared by a Bayesian network meta-analysis. Wang, Xue Zeng, Li Feng, Xue Zhao, Na Feng, Na Du, Xin Front Oral Health Oral Health BACKGROUND: Oral mucositis (OM) is one of the most common adverse effects of radiotherapy and chemotherapy. It greatly affects the patients' quality of life and hinders cancer treatment implementation. Treating OM with mouthwash is a widely used strategy that can effectively relieve symptoms and promote healing. However, the wide mouthwash selection confuses clinicians. This Bayesian network meta-analysis aimed to compare the effects of various mouthwash types used to treat OM and provide high-level evidence-based recommendations for OM treatment. METHODS: Database search included PubMed, Embase, Cochrane Library, and Web of Science from inception to April 21, 2022. The primary outcome was OM score improvement following the World Health Organization grades. The randomized controlled trial (RCT) bias risk assessment tool provided in the Cochrane Handbook assessed the studies' risk of bias. We performed pairwise and Bayesian network meta-analysis with random effects following the PRISMA guideline. RESULTS: The study included 13 RCTs with 570 patients. Pairwise comparisons showed that povidone-iodine was more effective than chlorhexidine (weighted mean difference [WMD], −2.64; 95% confidence interval [CI], −2.72 to −2.56) but inferior to granulocyte-macrophage colony-stimulating factor (GM-CSF; WMD, 0.20; 95% CI, 0.06–0.34) after one week of mouthwash treatment. Vitamin E (WMD, −0.94; 95% CI, −1.03 to −0.85), natural drugs (WMD, −0.93; 95% CI, −1.46 to −0.40), and phenytoin (WMD, −0.38; 95% CI, −0.59 to −0.17) exhibited better therapeutic effects than a placebo after three weeks of treatment. Bayesian network meta-analysis showed that povidone-iodine was superior to chlorhexidine in treating OM (WMD, 2.63; 95% CI, 0.20–5.01). Other mouthwashes showed no significant differences. Rank probability indicated that the best OM therapeutic mouthwashes were GM-CSF (54%), vitamin E (24%), and natural drugs (43%) after one, two, and three weeks of treatment, respectively. CONCLUSION: GM-CSF was the most effective mouthwash type for OM treatment. When considering the cost and effectiveness, povidone-iodine and sodium bicarbonate might be the most advantageous. Furthermore, natural drugs have the same potential in treating OM. Safety and acceptability are their most outstanding characteristic. Frontiers Media S.A. 2023-01-30 /pmc/articles/PMC9926969/ /pubmed/36798750 http://dx.doi.org/10.3389/froh.2022.977830 Text en © 2023 Wang, Zeng, Feng, Zhao, Feng and Du. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oral Health
Wang, Xue
Zeng, Li
Feng, Xue
Zhao, Na
Feng, Na
Du, Xin
Did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? The therapeutic effect compared by a Bayesian network meta-analysis.
title Did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? The therapeutic effect compared by a Bayesian network meta-analysis.
title_full Did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? The therapeutic effect compared by a Bayesian network meta-analysis.
title_fullStr Did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? The therapeutic effect compared by a Bayesian network meta-analysis.
title_full_unstemmed Did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? The therapeutic effect compared by a Bayesian network meta-analysis.
title_short Did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? The therapeutic effect compared by a Bayesian network meta-analysis.
title_sort did you choose appropriate mouthwash for managing chemoradiotherapy-induced oral mucositis? the therapeutic effect compared by a bayesian network meta-analysis.
topic Oral Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926969/
https://www.ncbi.nlm.nih.gov/pubmed/36798750
http://dx.doi.org/10.3389/froh.2022.977830
work_keys_str_mv AT wangxue didyouchooseappropriatemouthwashformanagingchemoradiotherapyinducedoralmucositisthetherapeuticeffectcomparedbyabayesiannetworkmetaanalysis
AT zengli didyouchooseappropriatemouthwashformanagingchemoradiotherapyinducedoralmucositisthetherapeuticeffectcomparedbyabayesiannetworkmetaanalysis
AT fengxue didyouchooseappropriatemouthwashformanagingchemoradiotherapyinducedoralmucositisthetherapeuticeffectcomparedbyabayesiannetworkmetaanalysis
AT zhaona didyouchooseappropriatemouthwashformanagingchemoradiotherapyinducedoralmucositisthetherapeuticeffectcomparedbyabayesiannetworkmetaanalysis
AT fengna didyouchooseappropriatemouthwashformanagingchemoradiotherapyinducedoralmucositisthetherapeuticeffectcomparedbyabayesiannetworkmetaanalysis
AT duxin didyouchooseappropriatemouthwashformanagingchemoradiotherapyinducedoralmucositisthetherapeuticeffectcomparedbyabayesiannetworkmetaanalysis